MS4A1 and B-cell non-Hodgkin lymphoma: Tumor‐specific neoantigens can be induced by ASOs; for instance, an ASO‐mediated shift in CD20 splicing generates a Δ‐CD20 isoform that triggers cytotoxic T‐cell responses, possibly overcoming Rituximab resistance in B‐cell lymphoma (NCT02844491) [236].